Update: 2024-04-29  Visitor: 0000624910
:::
Path: Home > News & Releases > What's New
Open new window, Share to Facebook. Open new window, Share to Line. Open new window, Share to X. Open new window, Share to Plurk. Print

What's New

Novel Targeted Therapy for Glaucoma
Organization: Department of Industrial Technology        Publish Date: 2023-12-07 09:30
Open new window for The Novel Targeted Therapy for Glaucoma, co-developed with TheratOcular Biotek.(jpg)
The Novel Targeted Therapy for Glaucoma, co-developed with TheratOcular Biotek, is a dual-target eye drop that significantly improves trabecular meshwork blockage and facilitates the drainage of aqueous humor to regulate intraocular pressure (IOP). This dual-target drug overcomes prevailing limitations of side effects and surpasses existing medications with three times the efficacy in reducing IOP. In addition to its efficacy in treating glaucoma, it is suitable for individuals with elevated intraocular pressure.
Hits:52

Go Back Top